Patient Guide: A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 71 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07680764
Status: UPCOMING
Condition: Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase: Phase II

Find a Study Location Near You

This study is available at 71 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Athens, Georgia
  • Lexington, Kentucky
  • Lexington, Kentucky
  • • And 68 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily